Skip to main content
Log in

A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1


  1. C. Ferraz, M. Eszlinger, R. Paschke, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J. Clin. Endocrinol. Metab. 96(7), 2016–2026 (2011)

    Article  CAS  Google Scholar 

  2. D.N. Poller, Z.W. Baloch, G. Fadda, S.J. Johnson, M. Bongiovanni, A. Pontecorvi, B. Cochand-Priollet, Thyroid FNA: new classifications and new interpretations. Cancer Cytopathol. 124(7), 457–466 (2016)

    Article  Google Scholar 

  3. C. Durante, G. Costante, G. Lucisano, R. Bruno, D. Meringolo, A. Paciaroni, E. Puxeddu, M. Torlontano, S. Tumino, M. Attard, L. Lamartina, A. Nicolucci, S. Filetti, The natural history of benign thyroid nodules. JAMA 313(9), 926–935 (2015)

    Article  CAS  Google Scholar 

  4. B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)

    Article  Google Scholar 

  5. G. Grani, L. Lamartina, V. Ascoli, D. Bosco, F. Nardi, F. D’Ambrosio, A. Rubini, L. Giacomelli, M. Biffoni, S. Filetti, C. Durante, V. Cantisani, Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules. Endocrine 57(2), 256–261 (2017)

    Article  CAS  Google Scholar 

  6. F. Nardi, F. Basolo, A. Crescenzi, G. Fadda, A. Frasoldati, F. Orlandi, L. Palombini, E. Papini, M. Zini, A. Pontecorvi, P. Vitti, Italian consensus for the classification and reporting of thyroid cytology. J. Endocrinol. Invest. 37(6), 593–599 (2014)

    Article  Google Scholar 

  7. M. Nishino, Molecular cytopathology for thyroid nodules: a review of methodology and test performance. Cancer Cytopathol. 124(1), 14–27 (2016)

    Article  Google Scholar 

  8. Y.E. Nikiforov, S.E. Carty, S.I. Chiosea, C. Coyne, U. Duvvuri, R.L. Ferris, W.E. Gooding, S.P. Hodak, S.O. LeBeau, N.P. Ohori, R.R. Seethala, M.E. Tublin, L. Yip, M.N. Nikiforova, Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120(23), 3627–3634 (2014)

    Article  CAS  Google Scholar 

  9. Cancer Genome Atlas Research Network, Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3), 676–690 (2014)

    Article  Google Scholar 

  10. P.S. Harper, Myotonic Dystrophy (Oxford University Press, Oxford, 2002)

  11. M. Santoro, M. Masciullo, R. Pietrobono, G. Conte, A. Modoni, M.L. Bianchi, V. Rizzo, M.G. Pomponi, G. Tasca, G. Neri, G. Silvestri, Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions. J. Neurol. 260(5), 1245–1257 (2013)

    Article  CAS  Google Scholar 

  12. I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126(3), 1052–1066 (2016)

    Article  Google Scholar 

  13. A. Verrienti, A. Carbone, P. Bellitti, M.C. Fabiano, R.F. De Rose, M. Maranghi, P. Lucia, C. Durante, F. Rosignolo, V. Pecce, M. Sponziello, C. Puppin, G. Costante, R. Bruno, A novel double mutation Val648ile and Val804leu of Ret proto-oncogene in multiple endocrine neoplasia type 2. Endocr. Pract. 21, 1248–1254 (2015)

    Article  Google Scholar 

  14. A. Karunamurthy, F. Panebianco, S. J Hsiao, J. Vorhauer, M.N. Nikiforova, S. Chiosea, Y.E. Nikiforov, Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules. Endocr. Relat. Cancer 23(4), 295–301 (2016)

    Article  CAS  Google Scholar 

  15. M.C. Topf, Z.X. Wang, K. Furlong, J.L. Miller, M. Tuluc, E.A. Pribitkin, EIF1AX mutation in a patient with Hürthle cell carcinoma. Endocr. Pathol. 29(1), 27–29 (2016).

    Article  Google Scholar 

  16. D.S. Olsen, E.M. Savner, A. Mathew, F. Zhang, T. Krishnamoorthy, L. Phan, A.G. Hinnebusch, Domains of eIF1A that mediate binding to eIF2, eIF3 and eIF5B and promote ternary complex recruitment in vivo. EMBO J. 22(2), 193–204 (2003)

    Article  CAS  Google Scholar 

  17. P.D. Stenson, M. Mort, E.V. Ball, K. Evansm, M. Hayden, S. Heywoodm, M. Hussain, A.D. Phillips, D.N. Cooper, The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum. Genet. 136(6), 665–677 (2017).

    Article  CAS  Google Scholar 

  18. A.K. Win, P.G. Perattur, J.S. Pulido, C.M. Pulido, N.M. Lindor, Increased cancer risks in myotonic dystrophy. Mayo Clin. Proc. 87(2), 130–135 (2012)

    Article  Google Scholar 

  19. M.L. Bianchi, E. Leoncini, M. Masciullo, A. Modoni, S.M. Gadalla, R. Massa, E. Rastelli, C. Terracciano, G. Antonini, E. Bucci, A. Petrucci, S. Costanzi, M. Santoro, S. Boccia, G. Silvestri, Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors. J. Neurol. 263(3), 492–498 (2016)

    Article  CAS  Google Scholar 

  20. R. Fernández-Torrón, M. García-Puga, J.I. Emparanza, M. Maneiro, A.M. Cobo, J.J. Poza, J.B. Espinal, M. Zulaica, I. Ruiz, L. Martorell, D. Otaegui, A. Matheu, A. López de Munain, Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation. Neurology 87(12), 1250–1257 (2016)

    Article  Google Scholar 

Download references


The study was supported by the Umberto Di Mario Foundation, the “Sapienza” University of Rome (grant RM11715C7DD0EF56 to S.F.) and by PRIN 2015 (grant Prot. 2015HPMLFY to C.D.).

Author information

Authors and Affiliations


Corresponding author

Correspondence to Antonella Verrienti.

Ethics declarations

Ethics approval

All procedures involving humans were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all subjects included in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sponziello, M., Silvestri, G., Verrienti, A. et al. A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma. Endocrine 62, 492–495 (2018).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: